Clinical trials
Recruiting Waldenstrom Macroglobulinemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2014 | 1 |
| 2020 | 1 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 7 |
| 2025 | 8 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 3 |
| UNC Lineberger Comprehensive Cancer Center | 3 |
| BeiGene | 2 |
| Centre Hospitalier Universitaire, Amiens | 2 |
| Dana-Farber Cancer Institute | 2 |
| Nurix Therapeutics, Inc. | 2 |
| iOMEDICO AG | 2 |
| Accutar Biotechnology Inc | 1 |
| Ascentage Pharma Group Inc. | 1 |
| BeOne Medicines | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Waldenstrom Macroglobulinemia | 45 |
| Lymphoma, B-Cell, Marginal Zone | 28 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 22 |
| Lymphoma, Follicular | 22 |
| Lymphoma, Mantle-Cell | 21 |
| Lymphoma, Large B-Cell, Diffuse | 14 |
| Lymphoma | 12 |
| Lymphoma, Non-Hodgkin | 11 |
| Recurrence | 5 |
| Burkitt Lymphoma | 4 |
Trials
Showing 26 to 45 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.